Dr. David O'Malley, MD
Claim this profileOhio State University Comprehensive Cancer Center
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
12 reported clinical trials
27 drugs studied
Area of expertise
1Ovarian Cancer
Stage IV
BRCA positive
MAGE-A4 positive
2Fallopian Tube Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials David O'Malley, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 210 criteria
Abemaciclib + Olaparib
for Recurrent Ovarian Cancer
This phase I/Ib trial identifies the side effects and best dose of abemaciclib when given together with olaparib in treating patients with ovarian cancer that responds at first to treatment with drugs that contain the metal platinum but then comes back within a certain period (recurrent platinum-resistant). Abemaciclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer.
Recruiting1 award Phase 110 criteria
More about David O'Malley, MD
Clinical Trial Related2 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments David O'Malley, MD has experience with
- Paclitaxel
- Bevacizumab
- Pembrolizumab
- NovoTTF-100L(O)
- Fulvestrant
- Tucatinib
Breakdown of trials David O'Malley, MD has run
Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Carcinoma
Cervical Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David O'Malley, MD specialize in?
David O'Malley, MD focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are BRCA positive.
Is David O'Malley, MD currently recruiting for clinical trials?
Yes, David O'Malley, MD is currently recruiting for 2 clinical trials in Columbus Ohio. If you're interested in participating, you should apply.
Are there any treatments that David O'Malley, MD has studied deeply?
Yes, David O'Malley, MD has studied treatments such as Paclitaxel, Bevacizumab, Pembrolizumab.
What is the best way to schedule an appointment with David O'Malley, MD?
Apply for one of the trials that David O'Malley, MD is conducting.
What is the office address of David O'Malley, MD?
The office of David O'Malley, MD is located at: Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210 United States. This is the address for their practice at the Ohio State University Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.